Wall Street Zen upgraded shares of Bank OZK (NASDAQ:OZK – Free Report) from a sell rating to a hold rating in a report issued on Sunday morning,Wall Street Zen reports. A number of other brokerages also recently commented on OZK. Morgan Stanley downgraded Bank OZK from an “equal weight” rating to an “underweight” rating and […]

Wall Street Zen cut shares of NextNav (NASDAQ:NN – Free Report) from a hold rating to a sell rating in a research report report published on Sunday,Wall Street Zen reports. NN has been the subject of a number of other research reports. Oppenheimer boosted their target price on NextNav from $25.00 to $50.00 and gave […]

Wall Street Zen upgraded shares of Adtalem Global Education (NYSE:CVSA – Free Report) from a hold rating to a buy rating in a research note released on Sunday,Wall Street Zen reports. A number of other analysts have also commented on CVSA. Barrington Research reaffirmed an “outperform” rating and set a $170.00 price objective on shares […]

Wall Street Zen lowered shares of Herbalife (NYSE:HLF – Free Report) from a buy rating to a hold rating in a research note issued to investors on Sunday,Wall Street Zen reports. HLF has been the topic of several other research reports. UBS Group set a $21.00 price objective on shares of Herbalife in a report […]

Wall Street Zen lowered shares of Installed Building Products (NYSE:IBP – Free Report) from a buy rating to a hold rating in a report published on Sunday morning,Wall Street Zen reports. A number of other research firms have also recently issued reports on IBP. Wells Fargo & Company decreased their price target on shares of […]

Wall Street Zen cut shares of Ionic Digital (NASDAQ:IOND – Free Report) from a hold rating to a sell rating in a research report sent to investors on Sunday morning,Wall Street Zen reports. IOND has been the topic of several other reports. BTIG Research started coverage on shares of Ionic Digital in a research report […]

Wall Street Zen lowered shares of AgomAb Therapeutics (NASDAQ:AGMB – Free Report) from a hold rating to a sell rating in a research note published on Sunday,Wall Street Zen reports. A number of other research firms have also recently commented on AGMB. Piper Sandler began coverage on AgomAb Therapeutics in a research report on Tuesday, […]